Skip to main content

Table 2 CNV Regions identified in discovery phase (MBCFS) and evaluated in replication cohort (Mayo VTE)

From: The association of copy number variation and percent mammographic density

Chromosome

Start position

End position

Number significant probesa

MBCFS (discovery)

Mayo VTE (replication)

3

163,995,377

164,008,284

17

1

3

164,030,569

164,108,060

13

0

8

133,134,063

133,144,009

6

0

11

11,779,614

11,780,713

17

0

17

47,649,105

47,667,700

3

3

  1. MBCFS Mayo Breast Cancer Family Study and Mayo VTE Mayo Venous Thromboembolism Case–Control Study.
  2. aSignificant associations defined as p < 0.0001 for discovery phase and p < 0.05 for replication.